Compliance Rate

Compliance Rate 40.0%
Compliant submissions 2
Incompliant submissions 3
Total trials 5

My Organizations' Clinical Trials

Showing 1975 of 2418 entries
View as:

Screening Trial for Pain Relief in Schwannomatosis (STARFISH)

Phase: N/A Priority: Normal
NCT ID: NCT05684692 Org: User:
Start: 08/31/23 End: 11/30/27 Due: 11/30/28

TMS for the Treatment of Primary Progressive Aphasia

Phase: N/A Priority: Normal
NCT ID: NCT04188067 Org: User:
Start: 03/01/22 End: 08/25/24 Due: 08/25/25

A Double-blind Randomized, Placebo-controlled, Crossover Study of Single Doses of OROS Methylphenidate Hydrochloride (CONCERTA) and Long-acting Methylphenidate Hydrochloride (RITALIN LA) in Healthy Adults

Phase: N/A Priority: Normal
NCT ID: NCT00302354 Org: User:
Start: 12/31/04 End: 09/30/05 Due: 09/30/06

Elucidating Kisspeptin Physiology by Blocking Kisspeptin Signaling

Phase: N/A Priority: Normal
NCT ID: NCT01438073 Org: User:
Start: 09/30/11 End: 04/30/16 Due: 04/30/17

A Skills-Based Program Delivered Via Secure Live Video to Patients With Acute Musculoskeletal Trauma

Phase: N/A Priority: Normal
NCT ID: NCT03405610 Org: User:
Start: 07/01/15 End: 08/01/18 Due: 08/01/19

Culturally Aware AET Non-Initiation Intervention

Phase: N/A Priority: Normal
NCT ID: NCT05465408 Org: User:
Start: 07/21/22 End: 06/30/25 Due: 06/30/26

Validation of Thermal Imaging to Detect Pneumonia

Phase: N/A Priority: Normal
NCT ID: NCT03261479 Org: User:
Start: 04/13/16 End: 06/01/20 Due: 06/01/21

Turmeric for Patients With Basal Joint Arthritis

Phase: N/A Priority: Normal
NCT ID: NCT03017118 Org: User:
Start: 08/09/17 End: 12/31/24 Due: 12/31/25

Study of TNF-Antagonism in Metabolic Syndrome

Phase: N/A Priority: Normal
NCT ID: NCT00409318 Org: User:
Start: 04/30/04 End: 05/31/05 Due: 05/31/06

Effects of Auditory Stimulation on Sleep and Memory in Schizophrenia

Phase: N/A Priority: Normal
NCT ID: NCT04783571 Org: User:
Start: 04/13/20 End: 12/31/25 Due: 12/31/26

Disease Management Platform for Heart Failure (DMP-HF)

Phase: N/A Priority: Normal
NCT ID: NCT04782973 Org: User:
Start: 03/11/21 End: 11/16/21 Due: 11/16/22

Voice Therapy Per the Rehabilitation Treatment Specification System

Phase: N/A Priority: Normal
NCT ID: NCT06152627 Org: User:
Start: 05/01/25 End: 08/31/27 Due: 08/31/28

Effects of Intensive Behavioral Training Program on Impulsivity and Inhibitory Control in Smokers

Phase: N/A Priority: Normal
NCT ID: NCT01314378 Org: User:
Start: 01/31/11 End: 10/31/12 Due: 10/31/13

Pediatric Healthy Weight Clinic

Phase: N/A Priority: Normal
NCT ID: NCT05020314 Org: User:
Start: 10/07/21 End: 12/31/23 Due: 12/31/24

Gefitinib in Treating Patients With Previously Untreated Stage IIIB or Stage IV Non-Small Cell Lung Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00411047 Org: User:
Start: 09/30/05 End: 12/31/12 Due: 12/31/13

Effectiveness of Antiretroviral Therapy During Acute HIV Infection

Phase: N/A Priority: Normal
NCT ID: NCT00705926 Org: User:
Start: 10/31/08 End: 07/16/17 Due: 07/16/18

Study of Regorafenib in Patients With Advanced Myeloid Malignancies

Phase: N/A Priority: Normal
NCT ID: NCT03042689 Org: User:
Start: 04/17/17 End: 02/27/23 Due: 02/27/24

Integrating Ketamine Effects on Neuronal Molecular Signatures and the Brain Functional and Structural Connectome

Phase: N/A Priority: Normal
NCT ID: NCT06698848 Org: User:
Start: 01/01/25 End: 06/30/30 Due: 06/30/31

Effect of Vyvanse on Driving in Young Adults With ADHD

Phase: N/A Priority: Normal
NCT ID: NCT00801229 Org: User:
Start: 12/31/08 End: 07/31/10 Due: 07/31/11

Enhancing Outcomes, Reducing Costs: Evaluating Peer Support for Mood Disorders

Phase: N/A Priority: Normal
NCT ID: NCT02242669 Org: User:
Start: 11/30/14 End: 04/30/17 Due: 04/30/18

ET 743 (Yondelis) in Men With Advanced Prostate Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00147212 Org: User:
Start: 06/30/02 End: 04/30/08 Due: 04/30/09

CRC Screening in Unscreened Individuals 45-54

Phase: N/A Priority: Normal
NCT ID: NCT06757192 Org: User:
Start: 01/31/25 End: 08/31/29 Due: 08/31/30

An Open-Label Trial of Buspirone for the Treatment of Anxiety in Youth With Autism Spectrum Disorders

Phase: N/A Priority: Normal
NCT ID: NCT01850355 Org: User:
Start: 07/31/13 End: 12/31/24 Due: 12/31/25

Optical Frequency Domain Imaging (OFDI) Assessment in Radiofrequency Ablation

Phase: N/A Priority: Normal
NCT ID: NCT01439594 Org: User:
Start: 10/31/08 End: 03/31/14 Due: 03/31/15

The T1D Parent Check-In: A Preventative Intervention

Phase: N/A Priority: Normal
NCT ID: NCT06160934 Org: User:
Start: 02/01/24 End: 06/30/26 Due: 06/30/27